Abstract:Chikungunya virus (CHIKV), a mosquito-borne alphavirus, causes acute febrile illness that can progress into chronic chikungunya virus disease (CHIKVD) marked by persistent debilitating arthralgia. At present, the exact cause of chronic CHIKVD is not understood, and in humans, the targets of CD4+ T cells in CHIKV are currently unknown. Here, by stimulating peripheral blood mononuclear cells (PBMCs) collected from patients suffering from chronic CHIKVD with peptides spanning the entire CHIKV genome, we provide a comprehensive landscape of CHIKV CD4+ T cell epitopes. We identified 123 novel CD4+ T cell epitopes and three immunodominant regions in E1, nsP1 and CP proteins. The immunodominance of these E1, nsP1 and CP regions was mapped to optimal epitopes, characterized by the capacity to bind to many common HLA class II allelic variants. In addition, we designed and validated a new CHIKV-specific CD4+ T cell epitope megapool, spanning both structural and non-structural proteins, which can be a useful tool to study CHIKV-specific T cell responses in small blood volumes, typically available in pediatric or clinical samples. Finally, by in silico assessment of the conservation of the CHIKV proteome in a diverse set of alphaviruses, we defined CHIKV epitopes conserved across arthritogenic and encephalitic viruses. Overall, our work is the first to identify CD4+ T cell targets of CHIKV in humans, expanding our capacity to study the role of T cells in CHIKV pathogenesis and mapping targets of alphaviruses for vaccine design.

What problem does this paper attempt to address?

### Problems the paper attempts to solve This paper aims to solve the problem of CD4+ T - cell epitope recognition in Chronic Chikungunya Virus Disease (CHIKVD) after Chikungunya virus (CHIKV) infection. Specifically, the research objectives include: 1. **Identify CD4+ T - cell epitopes in patients with chronic CHIKVD**: - By using a peptide library covering the entire CHIKV genome to stimulate peripheral blood mononuclear cells (PBMCs) of patients with chronic CHIKVD, comprehensively map the CHIKV CD4+ T - cell epitope atlas. - Identify 123 new CD4+ T - cell epitopes and determine three immunodominant regions in E1, nsP1 and CP proteins. 2. **Design and validate a CHIKV - specific CD4+ T - cell epitope polypeptide pool**: - Based on the identified epitopes, design a new CHIKV - specific CD4+ T - cell epitope polypeptide pool (megapool), which covers structural and non - structural proteins and can be used to study CHIKV - specific T - cell responses in small - volume blood samples, suitable for pediatric or clinical samples. 3. **Evaluate the conservation of CHIKV epitopes in other alphaviruses**: - By calculating the conservation of CHIKV epitopes in other arthritogenic and encephalitic alphaviruses, define CHIKV epitopes conserved in different alphaviruses, which is helpful for vaccine design and cross - virus research. ### Research background - **Chikungunya virus (CHIKV)**: A mosquito - transmitted alphavirus that causes an acute febrile illness and can develop into chronic CHIKVD, manifested as persistent joint pain. - **Chronic CHIKVD**: At present, the exact cause of chronic CHIKVD is still unclear, especially in humans, the CD4+ T - cell targets of CHIKV are not fully understood. - **The role of CD4+ T cells**: Multiple studies have shown that CD4+ T cells play an important role in the inflammatory response after CHIKV infection, but the specific epitope targets are not clear. ### Main findings - **Epitope identification**: By stimulating PBMCs with a peptide library, 123 new CD4+ T - cell epitopes were identified and immunodominant regions in E1, nsP1 and CP proteins were determined. - **Polypeptide pool design**: A CHIKV - specific CD4+ T - cell polypeptide pool containing these epitopes was designed, which is suitable for the study of small - volume blood samples. - **Conservatism analysis**: CHIKV epitopes are highly conserved in other arthritogenic alphaviruses, but less conserved in encephalitic alphaviruses. ### Significance - **Expand the understanding of the role of T cells in the pathological mechanism of CHIKV**: Identifying CD4+ T - cell epitopes helps to gain a deeper understanding of the role of T cells in chronic arthritis after CHIKV infection. - **Vaccine design**: Conserved epitopes can be used as potential targets for vaccine design, improving the broad - spectrum protection effect of vaccines. - **Clinical application**: The newly designed polypeptide pool can effectively detect CHIKV - specific T - cell responses in small - volume blood samples, which is suitable for clinical research and pediatric samples.

Identification of immunogenic and cross-reactive chikungunya virus-specific CD4+ T cell epitopes in chronic chikungunya viral arthritic disease in humans

Multiple Immune Factors Are Involved in Controlling Acute and Chronic Chikungunya Virus Infection

Development of a Novel Multi-Epitope Vaccine Based on Capsid and Envelope Protein Against Chikungunya Virus

Predicting Immunogenic Epitopes Variation of Envelope 2 Gene Among Chikungunya Virus Clonal Lineages by an In Silico Approach

A recombinant CHIKV-NLuc virus identifies chondrocytes as target of Chikungunya virus in a immunocompetent mouse model

Envelope specific T cell responses & cytokine profiles in chikungunya patients hospitalized with different clinical presentations

Interaction of chikungunya virus glycoproteins with macrophage factors controls virion production

Cytokine and T cell responses in post-chikungunya viral arthritis: A cross-sectional study

Comprehensive innate immune profiling of chikungunya virus infection in pediatric cases

Acute Chikungunya Virus Infection Triggers a Diverse Range of T Helper Lymphocyte Profiles

Identification of immunodominant T cell epitopes induced by natural Zika virus infection

Structural basis of Chikungunya virus inhibition by monoclonal antibodies

Innate immune response in patients with acute Chikungunya disease

Chikungunya virus infection disrupts MHC-I antigen presentation via nonstructural protein 2

Peptide Vaccine Against Chikungunya Virus: Immuno-Informatics Combined with Molecular Docking Approach.

Unraveling the Complexity of Chikungunya Virus Infection Immunological and Genetic Insights in Acute and Chronic Patients

Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya

Deep mutationally scanned (DMS) CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies

Dermal and Muscle Fibroblasts and Skeletal Myofibers Survive Chikungunya Virus Infection and Harbor Persistent RNA.

Chikungunya virus time course infection of human macrophages reveals intracellular signaling pathways relevant to repurposed therapeutics

Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening